Pyrosequencing AB
develops, manufactures and sells complete solutions for applied genetic
analysis based on its proprietary Pyrosequencing(tm) technology, a
simple-to-use DNA sequencing technique. In the post-genome era,
Pyrosequencing's technology has established the Company as one of the
leading suppliers of solutions for accurate, consistent DNA analysis in
research institutions and pharmaceutical, genomics and agbiotech
companies.
For the analysis of single nucleotide polymorphisms (SNPs), the
PSQ(tm)96 System with SNP Software and Reagent Kits is used by customers
such as AstraZeneca, GlaxoSmithKline, the Harvard Center for Cancer
Prevention, the National Institutes of Health (NIH), the Karolinska
Institute and DuPont Agriculture. The Company's Sequence Analysis
Software and Reagent Kits together with the PSQ 96 System are used for
the identification of gene-specific DNA sequences for applications such
as bacterial and viral typing where speed and ease of use are essential.
The Company is headquartered in Uppsala, Sweden with North American
operations located in Westborough, Massachusetts. Pyrosequencing AB also
has sales offices and distribution partners in Europe, Asia Pacific and
the Middle East. Pyrosequencing AB is listed on the OM Stockholm
Exchange. The Company's web address is
www.pyrosequencing.com. |
